After former CDC director Brenda Fitzgerald resigned earlier this year, Dr. Robert Redfield was chosen for the position on March 21. But his appointment is marred by reports about his controversial research background.
Robert Redfield tapped as CDC director, but people haven’t forgotten his controversial background
Report: Health IT sector dominated healthcare investments for the first time in the Midwest last year
A new BioEnterprise report showed that three mega deals powered the health IT sector to a record year in the Midwest in 2017.
Seattle Genetics lands fifth Adcetris approval as investors shrug
Adcetris made by Seattle Genetics for classical stage III or stage IV Hodgkin lymphoma has received FDA approval for use in combination with chemotherapy for previously untreated disease.
Providence St. Joseph Health Chief Digital Strategy Officer: AI is “still living in the land of the theoretical”
“It hasn’t necessarily proven its value in healthcare,” Sara Vaezy, chief digital strategy officer at Providence St. Joseph Health, said of artificial intelligence. “There’s an interesting potential future that could be re…
How can digital health startups steer clear of pilot study pitfalls?
It is an enormous challenge for digital health entrepreneurs to convince healthcare organizations to adopt their technology. But in the process of validating their products through pilot studies, they also need to avoid pitfalls that could undermine th…
How the current healthcare mindset is preventing wider digital health adoption
“In medicine, things go at a very different pace than in technology and science,” Dr. Homero Rivas, an assistant professor of surgery and the director of innovative surgery at Stanford University, said during a webinar hosted by VSee. While…
CMS gives a big boost to broad genomic tests by widening coverage for sequencing
Foundation Medicine and ThermoFisher Scientific are big beneficiaries of CMS widening its coverage and making a national coverage decision for next-generation sequencing of metastatic, Stage 3 or 4 and other cancers.
HIV research misconduct accusations loom over likely CDC pick
Dr. Robert Redfield, Trump’s likely pick to lead the CDC, is facing significant criticism because of a 20-year-old controversy over shoddy HIV research.